SARS-CoV-2

SARS-CoV-2 Overview

The novel coronavirus SARS-CoV-2 causing the COVID-19 pandemic has emerged quickly and is in the centre of global life science research.

SARS-CoV-2 Portfolio

We are happy to cooperate with our highly experienced partners Cellecta, Mawi DNA Technologies, Paragon Genomics and  YouSeq to offer their complete portfolio, including sample collection devices, qRT-PCR kits, NGS amplicon panels, lentiviral constructs for host and virus entry factor expression, pseudotyped lentiviral particles, and services.

SARS-CoV-2  NGS Panel

The newest additions to the portfolio are the CleanPlex SARS-CoV-2 FLEX NGS Panel which was developed by Paragon Genomics for sequencing of emerging virus mutations and Cellecta´s S-protein pseudotyped lentiviral particles featuring wild type spike-protein as well as all variants of concern.